TCL Archive Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants January 10, 1975
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development August 24, 1979